Cargando…

Commentary: Systemic immune-inflammatory indices and their association with ocular disorders—Do we have economical and reliable biomarkers?

Detalles Bibliográficos
Autor principal:	Madanagopalan, V G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350505/ https://www.ncbi.nlm.nih.gov/pubmed/32317463 http://dx.doi.org/10.4103/ijo.IJO_2100_19

Ejemplares similares

Commentary: Firework related ocular trauma – Have we learnt our lessons?
por: Tekchandani, Uday, et al.
Publicado: (2021)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Commentary: Artificial intelligence and smartphone fundus photography – Are we at the cusp of revolutionary changes in retinal disease detection?
por: Madanagopalan, V G, et al.
Publicado: (2020)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Commentary: Managing catastrophic antiphospholipid syndrome—do we have a way out?
por: Hirji, Sameer A., et al.
Publicado: (2021)

Commentary: Janus kinase inhibitors and their use in autoimmune ocular inflammatory disorders
por: Moreker, Mayur R
Publicado: (2020)

Commentary: Ocular lesions in leprosy – Should we forget?
por: Biswas, Jyotirmay, et al.
Publicado: (2022)

Commentary: The times have changed: Are we listening?
por: Grover, A K
Publicado: (2019)

Commentary: If it's difficult, we are doing something wrong
por: Shah, Ashish S.
Publicado: (2021)

Commentary: Systemic versus imaging biomarkers for diabetic macular oedema – Where do we stand?
por: Rana, Vipin, et al.
Publicado: (2021)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

Commentary: Coronary revascularization: How should we do it?
por: Sotolongo, Alex, et al.
Publicado: (2020)

Commentary: Malignant Glaucoma - Have we finally found an answer?
por: Kaushik, Sushmita
Publicado: (2019)

Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
por: Bertolaccini, Luca, et al.
Publicado: (2020)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Commentary: Do you have any doctors in your family?
por: Mays, Jarvis C., et al.
Publicado: (2021)

Commentary: How do we deal with a freak of nature?
por: Di Mauro, Michele, et al.
Publicado: (2021)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Commentary: Deep learning in retinopathy of prematurity: Where do we stand?
por: Sen, Parveen, et al.
Publicado: (2022)

Commentary: Hyperlactatemia after cardiac surgery: Yes we know it is bad but can we reliably prevent and treat it?
por: Omer, Shuab
Publicado: (2020)

Ocular surface inflammation in dry eye disease: What we know and what we do not
por: Vazirani, Jayesh
Publicado: (2018)

Do We Have a Channel Solution for ALS?
por: de Carvalho, Mamede
Publicado: (2015)

Commentary: Reliability in research
por: Babu, Naresh, et al.
Publicado: (2023)

Oxidative damage to DNA: do we have a reliable biomarker?
por: Collins, A R, et al.
Publicado: (1996)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?
por: Sainathan, Sandeep, et al.
Publicado: (2021)

Commentary: Has pathology gone to the “birds” because we have just been “winging” it?
por: Pantanowitz, Liron, et al.
Publicado: (2016)

Commentary: Applicability of optical coherence tomography angiography for imaging ocular biomarkers of systemic diseases
por: Sheth, Jay Umed
Publicado: (2022)

Commentary: Ocular endoscopy: An eye into the eye
por: Bhende, Muna, et al.
Publicado: (2021)

Commentary: Posterior subtenon triamcinolone - The unsung hero for managing various ocular disorders
por: Tripathy, Koushik
Publicado: (2023)

Commentary: On the reliability of causal claims
por: Weed, Douglas L.
Publicado: (2022)

Commentary: That's all folks! But what should we really do to repair the aortic valve?
por: Weltert, Luca, et al.
Publicado: (2021)

Commentary: Viral serology testing before cataract surgery: Where do we stand?
por: Nayak, Bhagabat, et al.
Publicado: (2022)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Commentary: Assessment of limbal ischemia in ocular burns
por: Radhakrishnan, Naveen, et al.
Publicado: (2019)

Commentary: Effect of exercise on ocular blood flow
por: Ratra, Dhanashree, et al.
Publicado: (2021)

Commentary: Demodex – Microscopic residents of the ocular biome
por: Singh, Aastha, et al.
Publicado: (2021)

Commentary: Waardenburg syndrome: Genetics and ocular features
por: Chakraborty, Koyel, et al.
Publicado: (2022)

Commentary: Evaluating ocular surface disease in glaucoma
por: Behera, Geeta, et al.
Publicado: (2022)

Commentary: Ocular myasthenia gravis: Interpreting the investigations
por: Nair, Akshay Gopinathan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uf5tpm8vsjp7qs0mijtn4gla23